Guozhong Gong
Publications by Year
Research Areas
Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Systemic Lupus Erythematosus Research, HIV/AIDS drug development and treatment
Most-Cited Works
- → Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB(2001)576 cited
- → Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection(2013)122 cited
- → Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial(2018)120 cited
- → HCV replication in PBMC and its influence on interferon therapy(2003)57 cited
- → miR-197 Expression in Peripheral Blood Mononuclear Cells from Hepatitis B Virus-Infected Patients(2013)39 cited
- → A phase 3, open‐label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin(2016)31 cited
- → Real‐world treatment patterns and clinical outcomes of HCV treatment‐naive patients in China: an interim analysis from the CCgenos study(2016)30 cited
- → p53 controls hepatitis C virus non-structural protein 5A-mediated downregulation of GADD45α expression via the NF-κB and PI3K–Akt pathways(2012)28 cited
- → Nomogram prediction of individual prognosis of patients with acute-on-chronic hepatitis B liver failure(2018)24 cited
- → Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study(2018)22 cited